Tecan consensus picture on Tuesday, stock anchored on the SIX Swiss Exchange
30.06.2026 - 13:44:52 | ad-hoc-news.deBy Anna Wagner, Analysts & Consensus desk. Reviewed prior to publication on 2026-06-30, 13:44.
Tecan (CH0012100191) opens Tuesday with a defined analyst landscape around the Swiss life sciences stock. The shares are listed on the SIX Swiss Exchange, setting a clear international anchor for investors following European mid caps.
What analysts say today
Consensus data for Tecan points to a mixed but structured view, with a spread of Buy, Hold and occasional Sell recommendations across the major houses, according to recent aggregated analyst pages on leading financial portals. The company sits alongside peers such as Bio-Techne and other diagnostics suppliers in many sector comparisons.
Average 12-month price targets compiled by data aggregators typically cluster in a moderate premium to the current share price, reflecting expectations of steady revenue growth rather than aggressive expansion. Rating distributions often show a majority of Buy and Hold stances, with only a minority of negative calls, underlining a cautious but constructive stance on the stock.
How Tecan is positioned
Tecan is regarded as a specialist provider of instruments and solutions for laboratory automation, serving pharmaceutical, biotech and diagnostics clients worldwide. In consensus commentary, analysts frequently highlight recurring revenue from services and consumables as a stabilizing factor in the business model.
Coverage notes also underline the company’s exposure to global research spending and diagnostic testing volumes, making the stock sensitive to capital expenditure cycles in the life sciences sector. Peer comparisons often mention larger players like Thermo Fisher and smaller niche firms, placing Tecan in the mid-cap innovation segment.
All news and analysis on the Tecan shares
Further company reports, consensus updates and price data on Tecan are available in the dedicated topic section and via the Investor Relations pages.
What the company sells
Tecan generates revenue primarily by supplying automated liquid handling workstations and microplate readers used in research, diagnostics and drug discovery laboratories. Complementary consumables, software and service contracts create recurring income streams that are central to analyst models.
Where the stock trades today
The Tecan shares (CH0012100191) trade on 2026-06-30, 13:44 on the SIX Swiss Exchange at a latest available indicative level in Swiss francs, reflecting intraday activity on the Zurich market.
Key data on the Tecan shares
- Company: Tecan Group AG
- ISIN: CH0012100191
- WKN: 897488
- Ticker: TECN
- Trading venue: SIX Swiss Exchange
- Price (as of 2026-06-30, 13:44): latest indicative level CHF
- Market cap: latest published figure CHF (as of 2026-06-30)
- Sector / industry: Health Care Equipment & Supplies
- Index membership: SPI Mid
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice or a recommendation to buy or sell any securities.
